Advertisement
News
Advertisement

Funding: Nevro Corp. Lands $48M in Support of Spinal Cord Stimulation Tech

Thu, 03/07/2013 - 1:12pm
Mass Device

California medical device maker raises $48 million in a Series C financing round in support of research and commercialization of its Senza spinal cord stimulation technology.

Nevro Corp. logo

Menlo Park, Calif.-based Nevro Corp. raised $48 million in a Series C financing round in support of its high-frequency spinal cord stimulation technology, including investments from Covidien (NYSE:COV) Ventures and Johnson & Johnson (NYSE:JNJ) Development Corp.

Nevro develops and markets the Senza HF-SCS system for treatment of chronic pain and other disorders. In July 2012 the company won FDA approval to begin a pivotal trial of the Senza system.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading